Medtronic plc (MDT)
- Previous Close
82.76 - Open
83.00 - Bid 82.03 x 1200
- Ask 84.00 x 800
- Day's Range
82.28 - 83.06 - 52 Week Range
68.84 - 91.00 - Volume
4,216,992 - Avg. Volume
6,193,229 - Market Cap (intraday)
109.997B - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
26.30 - EPS (TTM)
3.15 - Earnings Date May 23, 2024
- Forward Dividend & Yield 2.76 (3.33%)
- Ex-Dividend Date Mar 21, 2024
- 1y Target Est
94.00
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
www.medtronic.comRecent News: MDT
Performance Overview: MDT
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDT
Valuation Measures
Market Cap
110.00B
Enterprise Value
126.86B
Trailing P/E
26.30
Forward P/E
15.15
PEG Ratio (5yr expected)
1.57
Price/Sales (ttm)
3.42
Price/Book (mrq)
2.12
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
13.00%
Return on Assets (ttm)
4.23%
Return on Equity (ttm)
8.17%
Revenue (ttm)
32.32B
Net Income Avi to Common (ttm)
4.2B
Diluted EPS (ttm)
3.15
Balance Sheet and Cash Flow
Total Cash (mrq)
8.32B
Total Debt/Equity (mrq)
48.43%
Levered Free Cash Flow (ttm)
5.51B
Research Analysis: MDT
Company Insights: MDT
MDT does not have Company Insights